Jones Financial Companies’s VanEck Biotech ETF BBH Stock Holding History

Jones Financial Companies’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$733K	Sell	4,071 -279	-6%	-$53.8K	﹤0.01%	1856
2025 Q4	$823K	Buy	4,350 +1,802	+71%	+$333K	﹤0.01%	1311
2025 Q3	$413K	Sell	2,548 -22	-0.9%	-$3.59K	﹤0.01%	1474
2025 Q2	$393K	Sell	2,570 -265	-9%	-$39.5K	﹤0.01%	1375
2025 Q1	$449K	Buy	2,835 +218	+8%	+$35.4K	﹤0.01%	1178
2024 Q4	$411K	Sell	2,617 -108	-4%	-$18.2K	﹤0.01%	1068
2024 Q3	$481K	Buy	2,725 +52	+2%	+$9.23K	﹤0.01%	836
2024 Q2	$450K	Buy	2,673 +2,653	+13,265%	+$434K	﹤0.01%	590
2024 Q1	$3.33K	Buy	+20	New	+$3.31K	﹤0.01%	1218

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.26B AUM 24.75% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

Jones Financial Companies's BBH Position: Q1 2026 in Review

Jones Financial Companies reduced its VanEck Biotech ETF (BBH) stake by 6.4% in Q1 2026, selling an estimated $53.8K and leaving 4,071 shares worth $733K. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Jones Financial Companies first reported a position in BBH in Q1 2024 and has held it in 9 quarters since. The position peaked at $823K in Q4 2025. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

Jones Financial Companies held 4,071 shares of VanEck Biotech ETF worth $733K as of Q1 2026.
Jones Financial Companies sold 279 VanEck Biotech ETF shares in Q1 2026, an estimated $53.8K.
VanEck Biotech ETF made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #1856 holding.
Jones Financial Companies first reported a position in VanEck Biotech ETF in Q1 2024 and has held it in 9 quarters since.
Jones Financial Companies's VanEck Biotech ETF position peaked at $823K in Q4 2025.
112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.